You are here: Industry Insights > cancer

News List

A Rare Cancer 'Sarcoma' & the Need for a Multimodal Treatment Approach Shruti Talashi
December 09, 2024
A cancer that can develop anywhere in the body is sarcoma. Sarcomas disease is an uncommon type of cancer that appears in soft tissues and bones.
British Journal of Cancer: Zurletrectinib Is a Next-Generation TRK Inhibitor With Strong Intracranial Activity Against NTRK Fusion-Positive Tumors With On-Target Resistance to First-generation Agents July 31, 2024
Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumors with on-target resistance to first-generation agents.
Liposomal Irinotecan: A New Hope for The First-line Treatment of Metastatic Pancreatic Cancer YuZai
July 03, 2024
Pancreatic cancer, known as the king of cancer, was diagnosed with pancreatic ductal adenocarcinoma in approximately 496,000 people worldwide in 2020 and is the seventh leading cause of cancer-related deaths.
Broad-spectrum anti-cancer drug "returns" to China, and the market landscape has already changed drastically Yefenghong
May 27, 2024
Paclitaxel, a natural product extracted from taxus chinensis, acts on the microtubule to inhibit the mitosis of tumor cells and is one of the most important broad-spectrum chemotherapy drugs.
University of Liverpool to Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical Study PharmaSources
April 07, 2024
Touchlight announced an agreement with University of Liverpool for the use of dbDNA in the development of a fully-personalised therapeuticneoantigen DNA vaccine for patients with non-small cell lung cancer.
Live Biotherapeutics: Targeting The Microbiome For The Cancer Treatment Shruti Talashi
March 18, 2024
The quest to create microbial products that can influence cancer outcomes has been rekindled by the mounting evidence of the role that microbiota plays in human health and illness.
Cancer-Fighting CAR-T Cell Immunotherapy Potentially Induces New Cancers: An Analysis of Potential Safety Challenges Big Cat of Medical Field
March 06, 2024
Recent reports have indicated that the National Medical Products Administration has addressed the potential carcinogenicity associated with CAR-T cell immunotherapy.
Against Liver Cancer, Statins Helps Novel Liver Cancer Drug Development Yuntian/PharmaSources
April 20, 2023
Statins help to improve liver cancer and have been confirmed by a large number of clinical and scientific trials.
Immune Drug Combination Therapies for Liver Cancer: Analysis of the Clinical Studies of the Two Approved and Two First-line Drug Combinations PharmaSources/Yuntian
May 31, 2021
Liver cancer has recently drawn much attention by a Chinese movie star Ng Man-tat who died of liver cancer and the National Liver Day on Mar. 18.
Development of Anticancer Drugs for Ferroptosis: An Analysis of Representative Natural Products PharmaSources/Yuntian
May 08, 2021
Over the past years, anticancer strategies based on ferroptosis have been well acknowledged, leading to a boom in the development of anticancer drugs at home and abroad.